+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Tendinopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Tendinopathy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Graves' Orbitopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Orbitopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2025 - Product Thumbnail Image

Recessive Dystrophic Epidermolysis (RDEB) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rhinitis - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
West Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

West Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Androgen Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Androgen Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Schnitzler Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Schnitzler Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Formyl Peptide Receptor - Pipeline Insight, 2025 - Product Thumbnail Image

Formyl Peptide Receptor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Food Allergies - Pipeline Insight, 2025 - Product Thumbnail Image

Food Allergies - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complex Regional Pain Syndromes- Pipeline Insight, 2025 - Product Thumbnail Image

Complex Regional Pain Syndromes- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
TRPV1 Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

TRPV1 Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Purinoceptor P2Y12 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
IgE Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

IgE Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Apolipoprotein C-III Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Apolipoprotein C-III Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Factor XI Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Factor XI Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neonatal Fc Receptor Antagonists- Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Fc Receptor Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Complement C1s Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1s Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more